Mitochondrial Regulation of Ferroptosis in Cancer Therapy

Int J Mol Sci. 2023 Jun 12;24(12):10037. doi: 10.3390/ijms241210037.

Abstract

Ferroptosis, characterized by glutamate overload, glutathione depletion, and cysteine/cystine deprivation during iron- and oxidative-damage-dependent cell death, is a particular mode of regulated cell death. It is expected to effectively treat cancer through its tumor-suppressor function, as mitochondria are the intracellular energy factory and a binding site of reactive oxygen species production, closely related to ferroptosis. This review summarizes relevant research on the mechanisms of ferroptosis, highlights mitochondria's role in it, and collects and classifies the inducers of ferroptosis. A deeper understanding of the relationship between ferroptosis and mitochondrial function may provide new strategies for tumor treatment and drug development based on ferroptosis.

Keywords: cancer; ferroptosis; iron; mitochondria; oxidative damage.

Publication types

  • Review

MeSH terms

  • Cell Death
  • Ferroptosis*
  • Humans
  • Iron / metabolism
  • Lipid Peroxidation
  • Mitochondria / metabolism
  • Neoplasms* / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Iron
  • Reactive Oxygen Species

Grants and funding

This work was financed by the National Natural Science Foundation of China (No. 81870591), Key R&D and Promotion Projects in Henan Province (Nos. 222102310013, 222102310290, and 202102310034), Key Scientific Research Projects of Colleges and Universities in Henan Province (Nos. 23A310011 and 22A310001), and the Kaifeng Science and Technology Development Plan (No. 2203012).